Angiogenesis promoted by caged growth factors
View Patent ↗The present disclosure relates to controlling the release of growth factors for the promotion of angiogenesis. The growth factors or a polymer matrix are modified by photoactive compounds, such that the growth factors are not released into an active form until they are irradiated with light. The disclosure also relates to tissue engineering scaffolds comprising one or more polymers and at least two growth factors.
1. A method for promoting angiogenesis at a target site in a mammalian subject comprising:
administering to a mammalian subject a formulation comprising at least two growth factors, wherein a first growth factor is released in a bioactive state in response to a first spectral sensitivity range and a second growth factor is released in a bioactive state in response to a second spectral sensitivity range;
irradiating the target site with a first wavelength of light in the first spectral sensitivity range to release the first growth factor; and
irradiating the target site with a second wavelength of light in the second spectral sensitivity range to release the second growth factor;
wherein the sequential administration of the first growth factor and the second growth factor promotes angiogenesis at the target site.
2. The method of claim 1 , wherein one or more of the at least two growth factors are caged.
3. The method of claim 2 , wherein the one or more caged growth factors are not released in a bioactive state until radiated.
4. The method of claim 1 , wherein the formulation further comprises one or more polymers.
5. The method of claim 4 , wherein the one or more polymers are selected from the group consisting of poly(lactic acid)polymers, poly(glycolic acid)polymers, poly(lactide-co-glycolides) (PLGA), poly(urethanes), poly(siloxanes) or silicones, poly(ethylene), poly(vinyl pyrrolidone), poly(2-hydroxy ethyl methacrylate), poly(N-vinyl pyrrolidone), poly(methyl methacrylate), poly(vinyl alcohol) (PVA), poly(acrylic acid), poly(vinyl acetate), polyacrylamide, poly(ethylene-co-vinyl acetate), poly(ethylene glycol), poly(methacrylic acid), polylactic acid (PLA), polyglycolic acids (PGA), nylons, polyamides, polyanhydrides, poly(ethylene-co-vinyl alcohol) (EVOH), polycaprolactone, poly(vinyl acetate), polyvinylhydroxide, poly(ethylene oxide) (PEO), and polyorthoesters or a co-polymer formed from at least two members of the group.
6. The method of claim 4 , wherein the one or more polymers comprise a photoactive group that cleaves the polymer in response to light thereby releasing a growth factor entrained therein.
7. The method of claim 4 , wherein the one or more polymers comprise a group sensitive to degradation by a photoacid.
8. The method of claim 1 , wherein the first and second spectral sensitivity ranges are not substantially overlapping.
9. The method of claim 1 , wherein the at least two growth factors are independently selected from the group consisting of: transforming growth factor-alpha (TGF-α), transforming growth factor-beta (TGF-β), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), nerve growth factor (NGF), brain derived neurotrophic factor, cartilage derived factor, bone growth factor (BGF), basic fibroblast growth factor, insulin-like growth factor (IGF), vascular endothelial growth factor (VEGF), granulocyte colony stimulating factor (G-CSF), hepatocyte growth factor, glial neurotrophic growth factor (GDNF), stem cell factor (SCF), keratinocyte growth factor (KGF), and skeletal growth factor.
10. The method of claim 1 , wherein the first growth factor is VEGF and the second growth factor is PDGF.
11. The method of claim 1 , wherein an amplitude of the irradiating of the target site controls a rate of release of the first growth factor, the second growth factor, or both.
12. The method of claim 1 , wherein the irradiating comprises illumination with a laser, a mercury bulb, or an electromagnetic radiation source in combination with a filter.